abstract |
FIELD: medicine, clinical pharmacology. SUBSTANCE: invention proposes the use of Baikal skullcap (Scutellaria) extract for correction of energy metabolism disorders in brain at hypoxia state. The proposed agent shows the enhanced antihypoxic effect as compared with the known antihypoxic agents. EFFECT: enhanced effectiveness of an agent, absence of adverse effects. 1 cl, 7 tbl, 4 ex |